Larvol Delta - Ashvattha-Therapeutics-Announces-Positive-Interim-Data-from-Ongoing-Phase-2-PRANA-Clinical-Study-of-OP101-in-Severe-COVID19-Patients

dendrimer N-acetyl-cysteine (OP-101) - Ashvattha Therap

https://www.businesswire.com/news/home/20210615005466/en/Ashvattha-Therapeutics-Announces-Positive-Interim-Data-from-Ongoing-Phase-2-PRANA-Clinical-Study-of-OP-101-in-Severe-COVID-19-Patients

Jun 15, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next